May 29, 2019

No Image

The Month in Movies: What’s in Theaters This June

As we venture forth into the heart of the summer movie season, the month of June brings us more superheroes, more action, some highly anticipated animated features and a plethora of sequels, spin-offs and reboots (some of them a combination of those things). Interestingly, we’re also getting a number of releases involving evil dolls, as well as a couple of musical hits from across the pond.

Below is our guide to all the major titles coming to theaters in June and how to get your tickets now.

June 7:

Dark Phoenix

Starring: Sophie Turner, Jennifer Lawrence, James McAvoy

The latest installment of the X-Men movie franchise (and final sequel in Fox’s main series before the characters enter Disney’s Marvel Cinematic Universe). Dark Phoenix reprises the comic book storyline in which Jean Grey (Sophie Turner) becomes too powerful for her own good, and so she turns bad. Jessica Chastain joins the cast for this follow-up to X-Men: Apocalypse in a mysterious role, while that movie’s X-Men team returns for this 1990s-set blockbuster.

[embedded content]

Get Tickets

Late Night

Starring: Emma Thompson, Mindy Kaling, John Lithgow

One of the biggest hits of this year’s Sundance Film Festival, Late Night is about a legendary talk show host (Thompson) whose long-running show is about to replace her. Kaling (The Office), who plays a last-minute hire for the program’s otherwise all-male writing team, also penned the screenplay for the comedy, which Fandango’s Erik Davis called “very timely” and “whip-smart.” Lithgow is the late night show host’s husband, and Ike Barinholtz plays her potential successor.

[embedded content]

Get Tickets

The Secret Life of Pets 2

Starring (voices): Patton Oswalt, Kevin Hart, Harrison Ford

Welcome back to New York, this animated sequel is waiting for you. And so are the many lovable domestic animals from the original The Secret Life of Pets, which was a huge hit in the summer of 2016. Oswalt takes over the role of Max the dog, whose home life has experienced another major change, while Hart returns as the voice of the cute but tough bunny Snowball and Ford makes his animated feature debut as a farm-dwelling sheepdog named Rooster.

[embedded content]

Get Tickets

June 14:

Men in Black International

Starring: Tessa Thompson, Chris Hemsworth, Liam Neeson

Emma Thompson also appears in this Men in Black spin-off reboot, reprising her character from the 2012 sequel Men in Black 3. The new movie takes the franchise across the pond to the UK HQ of the MIB as Tessa Thompson plays a new recruit to the alien-monitoring, Earth-protecting organization. She teams up with a hot shot agent (Hemsworth), and their mission is to save the planet from one of their own. Kumail Nanjiani co-stars as the voice of an extra-terrestrial sidekick.

[embedded content]

Get Tickets

Shaft

Starring: Jessie T. Usher, Samuel L. Jackson, Richard Roundtreee

What’s the movie franchise where two of the sequels have the same title as the original? (Shaft) Right on. Roundtree is back as the iconic private detective John Shaft from the 1971 Shaft, while Jackson reprises his role as his nephew, John Shaft II, from the 2000 movie also called Shaft. This time the focus is on that man’s son, John Shaft Jr. (Usher), an FBI agent who must team up with his two elder heroes for a murder investigation that takes them into the Harlem underworld.

[embedded content]

Get Tickets

June 21:

Anna

Starring: Sasha Luss, Helen Mirren, Cillian Murphy

From Luc Besson, writer and director of The Fifth Element, La Femme Nikita and Lucy, comes another action movie involving a kick-ass heroine. Newcomer Luss, a Russian supermodel turned actress, is the titular Anna, a Russian supermodel turned secret government assassin, one of the world’s deadliest. Mirren plays her handler, while Murphy and Luke Evans also co-star in what’s being sold as “an electrifying thrill ride” with “startling twists.”

[embedded content]

Get Tickets

Child’s Play

Starring: Aubrey Plaza, Gabriel Bateman, Mark Hamill (voice)

Chucky gets a fresh start with this reboot featuring Luke Skywalker himself, Mark Hamill, as the voice of the deadly doll. Plaza stars in the new version, which takes the franchise back to its horror roots, as a single mother who mistakenly buys her son (Bateman) an evil toy with artificial intelligence. The cast of the remake also includes Brian Tyree Henry (If Beale Street Could Talk), who plays the detective investigating Chucky’s murders, and Tim Matheson as a toy company CEO.

[embedded content]

Get Tickets

Toy Story 4

Starring (voices): Tom Hanks, Tim Allen, Tony Hale

While the grown-ups are watching the Child’s Play redo, the kids get their own movie about sentient toys. The fourth installment of Pixar’s flagship franchise follows Woody (Hanks), Buzz (Allen) and the rest of the gang of playthings on an existential adventure, during which they meet a new character called Forky (Hale) made out of a spork and googly eyes. Other additions include Keanu Reeves as a daredevil action figure and Christina Hendricks as a villainous doll.

[embedded content]

Get Tickets

Wild Rose

Starring: Jessie Buckley, Matt Costello, Jane Patterson

Irish singer Jessie Buckley, who broke out on the BBC talent show I’d Do Anything, leads this award-winning drama about a Scottish mother of two who, after being released from prison, travels to America to find fame as a country music star. Harry Potter actress Julie Walters and Game of Thrones actor Jamie Sives also feature in the movie, which has been receiving rave reviews on the film festival circuit since its Toronto premiere last fall.

[embedded content]

Get Tickets

June 26:

Annabelle Comes Home

Starring: Vera Farmiga, Patrick Wilson, Mckenna Grace

For those who haven’t had their fill of evil dolls with Child’s Play and Toy Story 4, this Annabelle sequel rounds out the trio just days later. Farmiga and Wilson reprise their roles as real-life paranormal investigators Lorraine and Ed Warren from other installments of the Conjuring Universe horror franchise, while Captain Marvel‘s Mckenna Grace co-stars as their young daughter, who becomes the target of the Annabelle doll’s terror.

[embedded content]

Get Tickets

June 28:

Yesterday

Starring: Himesh Patel, Lily James, Kate McKinnon

Slumdog Millionare and Trainspotting director Danny Boyle teamed up with Love Actually and Notting Hill writer Richard Curtis for this fantasy comedy about a musician (Patel) who wakes up in an alternate timeline in which The Beatles never existed. But he still remembers their songs and so becomes famous performing such hits as the eponymous “Yesterday.” James co-stars as his best friend, McKinnon plays his agent, and singer-songwriter Ed Sheeran appears as himself.

[embedded content]

Get Tickets

Let’s block ads! (Why?)


No Image

Uber To Start Banning Passengers With Low Ratings

Uber announced this week that it is changing policies and banning riders with low scores.

Justin Sullivan/Getty Images


hide caption

toggle caption

Justin Sullivan/Getty Images

Uber has unveiled a new policy that enables the company to kick riders with low ratings to the curb.

For years, Uber allowed passengers to rate drivers on a star system, ultimately allowing customers to influence whether drivers can stay behind the wheel. Internal charts from 2014 published by Business Insider showed that drivers with ratings of 4.6 or below were at risk for the boot.

Though drivers could rate passengers, there was no equivalency in consequences. But now Uber’s drivers will have a greater say about the behavior of passengers.

“Respect is a two-way street, and so is accountability,” Kate Parker, Uber’s head of Safety Brand and Initiatives, said in a statement released Tuesday. Parker added, “While we expect only a small number of riders to ultimately be impacted by ratings-based deactivations, it’s the right thing to do.”

The shift will begin in the United States and Canada, the company said.

Riders will start to see a screen on the app that summarizes community guidelines and then asks them to confirm their understanding of the new terms. They will receive tips on how to increase their scores — suggestions like being polite, taking their trash out of the vehicle and refraining from asking drivers to speed.

Before passengers are deactivated, they will have multiple chances to boost their scores.

Uber didn’t say what the thresholds will be for passengers to lose access to the ride-hailing service.

“Each city has its own minimum threshold which is directly related to the average rider rating in that city,” Uber spokesperson Grant Klinzman told NPR by email.

Anyone can check their rating on the Uber app by visiting the main menu and looking at the number under their username.

Riders will also lose access to Uber’s food delivery app and JUMP, which allows people to rent electric bikes and scooters, Klinzman added.

A spokesperson for the Independent Drivers Guild, which represents more than 65,000 app-based drivers in New York, praised Uber’s announcement as a way to protect drivers in addition to riders.

“While most riders are respectful, banning riders who threaten driver safety, spew racist rants, and disrespect or damage our vehicles is the right thing to do,” spokesperson Moira Muntz said in a statement. “For too long there has been one-sided accountability and this is a positive step toward correcting that.”

Video footage recently showed a Lyft driver being brutally beaten by a rider in Queens.

Let’s block ads! (Why?)


No Image

AIDS Activists Take On The High Price Of HIV Prevention Pill

In the 1980s, AIDS activists demanded action from the U.S. government in a dramatic way, and got results. Now, they have a new goal: more affordable access to an HIV prevention pill.



ARI SHAPIRO, HOST:

In the 1980s and ’90s, a group of AIDS activists called ACT UP demanded action from the U.S. government in a dramatic way.

(SOUNDBITE OF PROTEST)

UNIDENTIFIED PEOPLE: Act up. Fight back. Fight AIDS.

SHAPIRO: This was 1988. AIDS was a national crisis. Activists swarmed the Food and Drug Administration in Rockville, Md. They laid down beside paper gravestones.

(SOUNDBITE OF PROTEST)

UNIDENTIFIED PERSON #1: You’re killing us. You’re killing us.

SHAPIRO: And they got results, including price reductions on HIV drugs that save lives. Now AIDS activists have a new goal – more affordable access to an HIV prevention pill. The pill is called TRUVADA, or PrEP. It’s made by Gilead Sciences and can cost up to $1,800 a month. NPR’s Selena Simmons-Duffin has the story.

SELENA SIMMONS-DUFFIN, BYLINE: A few weeks back at the AIDSWatch conference, Dr. Robert Redfield, who directs the Centers for Disease Control and Prevention, spoke.

(SOUNDBITE OF ARCHIVED RECORDING)

ROBERT REDFIELD: In this initiative…

SIMMONS-DUFFIN: He was selling the Trump administration’s plan to end HIV in America by 2030.

(SOUNDBITE OF ARCHIVED RECORDING)

UNIDENTIFIED PERSON #2: People can’t afford it because you don’t enforce it.

SIMMONS-DUFFIN: Things got hectic.

(SOUNDBITE OF ARCHIVED RECORDING)

UNIDENTIFIED PERSON #3: The medication we need…

SIMMONS-DUFFIN: Then earlier this month at the Gilead shareholders meeting…

EMILY SANDERSON: Gilead, your price-gouging is killing people.

SIMMONS-DUFFIN: A video shows a 20-something woman in the room facing men in suits who exchange looks.

SANDERSON: I’m disgusted by the fact that you would put profiteering ahead of the lives of people like me.

SIMMONS-DUFFIN: The group behind these disruptions is called PrEP4All, an offshoot of ACT UP. They’re out in force now because of the activity around the government’s HIV 2030 plan. That goal can only be reached if more people get on PrEP, which stands for pre-exposure prophylaxis. Only a fraction of the 1 million people at risk for HIV are on it.

PrEP4All wants that $1,800 a month for PrEP way lower, more like the $5 a month it costs in other countries. They have two approaches – shame Gilead into voluntarily lowering the price and pressure the government into challenging Gilead’s patent so generic competition forces the price down. Let’s start with Gilead.

SANDERSON: Our goal is to get Gilead Sciences to release the patent on TRUVADA, or PrEP.

SIMMONS-DUFFIN: Emily Sanderson is a co-founder of PrEP4All. You heard her confronting Gilead shareholders.

SANDERSON: Gilead has the power to make PrEP available right now for everybody, and they’re not doing it.

SIMMONS-DUFFIN: In a statement, the company told NPR it, quote, “respects the work of HIV advocates and has been engaged with the advocate community for decades.” But that price tag remains.

(SOUNDBITE OF ARCHIVED RECORDING)

DANIEL O’DAY: The current list price is $1,780 in the United States.

SIMMONS-DUFFIN: That’s CEO Daniel O’Day testifying about this issue on Capitol Hill a few weeks ago. Gilead is the only company making this drug in the U.S. right now. It’s under patent for a limited time, and shareholders want to see profits.

(SOUNDBITE OF ARCHIVED RECORDING)

O’DAY: The pricing as set in the United States takes into account the innovation it brings, the cost of the health care of treating an HIV patient, the ability to invest back in research and development and then also to make sure our access programs are effective.

SIMMONS-DUFFIN: Gilead argues the price isn’t the problem. Lack of awareness, stigma and homophobia are the problems. And they say few pay the full list price. Gilead provides the drug at a discount to government programs. They just donated drugs to the CDC to cover some uninsured patients. And people with high deductibles can use its copay assistance program. PrEP4All activists are dismissive of these efforts, in Jake Powell’s case, because of personal experience.

JAKE POWELL: Gilead’s copay assistance program for the first year paid out the full cost of those first few months to the point that my insurance then kicked in.

SIMMONS-DUFFIN: And paid full price for TRUVADA. The next year, Powell’s insurer stopped counting Gilead’s payments towards the $5,000 deductible. Powell would have had to pay out of pocket.

POWELL: I was off it for about six months because I couldn’t afford it. It was really frustrating. I was definitely scared in a way that I was used to not having to be scared.

SIMMONS-DUFFIN: PrEP4All says to Gilead, you’ve made billions already; just lower the cost of the drug. To the government, PrEP4All says…

SANDERSON: The CDC can come in and reduce the cost of PrEP and provide it at an affordable price.

SIMMONS-DUFFIN: That’s Emily Sanderson again. Activists make two points – that the CDC has its own patents for PrEP the agency could be enforcing, something Gilead disputes, and that taxpayer money was used in the studies underlying Gilead’s TRUVADA patent. The government has the power under the Bayh–Dole Act of 1980, they argue, to march in and break Gilead’s patent in the name of public health and let generic competition bring the price down.

SANDERSON: This PrEP pricing issue is a fixable problem. And we can get PrEP to everyone who needs it.

SIMMONS-DUFFIN: Neither the CDC nor Gilead have shown signs of being moved by these arguments. If the activists don’t convince them to act, the 1 million people at risk for HIV will have to wait until Gilead’s TRUVADA patent expires next fall and then wait again for generic competition to possibly lower the price closer to that $5 a month people get in the rest of the world. Selena Simmons-Duffin, NPR News.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)